TrademarkDir
GALECTIN THERAPEUTICS GT
LIVE

Serial Number

85873661

Owner

Galectin Therapeutics Inc.

Attorney

Joseph Agostino

First Use Date

Jun 27, 2013

Filing Date

Mar 12, 2013

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

GALECTIN THERAPEUTICS GT Trademark

Serial Number: 85873661 • Registration: 4492469

GALECTIN THERAPEUTICS GT is a trademark filed by Galectin Therapeutics Inc. on March 12, 2013. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Galectin Therapeutics Inc. (4 trademarks)

Suite 34
Newton, MA 02459

Entity Type: 03

Trademark Details

Filing Date

March 12, 2013

Registration Date

March 4, 2014

First Use Anywhere

June 27, 2013

First Use in Commerce

June 27, 2013

Published for Opposition

September 10, 2013

Goods & Services

Pharmaceutical preparations, namely, compounds for use in the treatment of nonalcoholic steatohepatitis, fibrosis, inflammatory and autoimmune disorders, neoplastic conditions, cancer, liver fibrosis, kidney fibrosis, lung fibrosis and/or heart fibrosis

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
May 13, 2024 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
May 13, 2024 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
May 13, 2024 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 13, 2024 APRE
TEAS SECTION 8 & 9 RECEIVED
Jan 26, 2024 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Mar 4, 2023 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 5, 2020 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 5, 2020 C15A
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Jun 5, 2020 EROP
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Apr 6, 2020 PR23
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Apr 1, 2020 EROP
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Oct 1, 2019 PR23
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 20, 2019 APRE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 13, 2019 TCCA
TEAS SECTION 8 & 15 RECEIVED
Aug 13, 2019 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 8, 2019 TCCA
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 4, 2019 REM1
REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Dec 3, 2018 CORV
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 3, 2018 EWAF
REGISTERED-PRINCIPAL REGISTER
Mar 4, 2014 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 28, 2014 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Jan 27, 2014 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 20, 2014 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 18, 2013 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 9, 2013 AITU
USE AMENDMENT FILED
Nov 11, 2013 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 11, 2013 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 5, 2013 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 10, 2013 NPUB
PUBLISHED FOR OPPOSITION
Sep 10, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 21, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 5, 2013 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 30, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 16, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 16, 2013 CRFA
ASSIGNED TO LIE
Jul 9, 2013 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 3, 2013 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 23, 2013 GNRN
NON-FINAL ACTION E-MAILED
Jun 23, 2013 GNRT
NON-FINAL ACTION WRITTEN
Jun 23, 2013 CNRT
ASSIGNED TO EXAMINER
Jun 21, 2013 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 19, 2013 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2013 NWOS
NEW APPLICATION ENTERED
Mar 15, 2013 NWAP

Related Trademarks

More from this Owner

GT logo

GT

GALECTIN THERAPEUTICS

GALECTIN THERAPEUTICS

GT logo

GT

GT logo

GT

GALECTIN THERAPEUTICS

GALECTIN THERAPEUTICS

DAVANAT

DAVANAT